Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
Clinical trial NCT03820141 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03820141
- Sponsor
- The Methodist Hospital Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2024-10-30
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.